161 related articles for article (PubMed ID: 22110587)
1. An MSI tumor specific frameshift mutation in a coding microsatellite of MSH3 encodes for HLA-A0201-restricted CD8+ cytotoxic T cell epitopes.
Garbe Y; Maletzki C; Linnebacher M
PLoS One; 2011; 6(11):e26517. PubMed ID: 22110587
[TBL] [Abstract][Full Text] [Related]
2. Identification of an HLA-A0201-restricted CTL epitope generated by a tumor-specific frameshift mutation in a coding microsatellite of the OGT gene.
Ripberger E; Linnebacher M; Schwitalle Y; Gebert J; von Knebel Doeberitz M
J Clin Immunol; 2003 Sep; 23(5):415-23. PubMed ID: 14601650
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells.
Schwitalle Y; Linnebacher M; Ripberger E; Gebert J; von Knebel Doeberitz M
Cancer Immun; 2004 Nov; 4():14. PubMed ID: 15563124
[TBL] [Abstract][Full Text] [Related]
4. Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO).
Linnebacher M; Wienck A; Boeck I; Klar E
J Biomed Biotechnol; 2010; 2010():841451. PubMed ID: 20339516
[TBL] [Abstract][Full Text] [Related]
5. A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells.
Saeterdal I; Gjertsen MK; Straten P; Eriksen JA; Gaudernack G
Cancer Immunol Immunother; 2001 Nov; 50(9):469-76. PubMed ID: 11761441
[TBL] [Abstract][Full Text] [Related]
6. Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens.
Linnebacher M; Gebert J; Rudy W; Woerner S; Yuan YP; Bork P; von Knebel Doeberitz M
Int J Cancer; 2001 Jul; 93(1):6-11. PubMed ID: 11391614
[TBL] [Abstract][Full Text] [Related]
7. Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancers.
Maletzki C; Schmidt F; Dirks WG; Schmitt M; Linnebacher M
Eur J Cancer; 2013 Jul; 49(11):2587-95. PubMed ID: 23561850
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of HLA-A2-restricted neoepitopes for immunotherapy of non-microsatellite instability-high colorectal cancer.
Shi R; Li Y; Ran L; Dong Y; Zhou X; Tang J; Han L; Wang M; Pang L; Qi Y; Wu Y; Gao Y
Sci China Life Sci; 2022 Mar; 65(3):572-587. PubMed ID: 34236583
[TBL] [Abstract][Full Text] [Related]
9. Opportunities for immunotherapy in microsatellite instable colorectal cancer.
Westdorp H; Fennemann FL; Weren RD; Bisseling TM; Ligtenberg MJ; Figdor CG; Schreibelt G; Hoogerbrugge N; Wimmers F; de Vries IJ
Cancer Immunol Immunother; 2016 Oct; 65(10):1249-59. PubMed ID: 27060000
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase (hTERT).
Liao ZL; Tang XD; Lü MH; Wu YY; Cao YL; Fang DC; Yang SM; Guo H
Cancer Sci; 2012 Nov; 103(11):1920-8. PubMed ID: 22909416
[TBL] [Abstract][Full Text] [Related]
11. Aberrant protein expression and frequent allelic loss of MSH3 in colorectal cancer with low-level microsatellite instability.
Plaschke J; Preußler M; Ziegler A; Schackert HK
Int J Colorectal Dis; 2012 Jul; 27(7):911-9. PubMed ID: 22249440
[TBL] [Abstract][Full Text] [Related]
12. Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes.
Michel S; Linnebacher M; Alcaniz J; Voss M; Wagner R; Dippold W; Becker C; von Knebel Doeberitz M; Ferrone S; Kloor M
Int J Cancer; 2010 Aug; 127(4):889-98. PubMed ID: 20013806
[TBL] [Abstract][Full Text] [Related]
13. Identification of two new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from colorectal carcinoma-associated antigen PLAC1/CP1.
Liu F; Zhang H; Shen D; Wang S; Ye Y; Chen H; Pang X; Song Q; He P
J Gastroenterol; 2014 Mar; 49(3):419-26. PubMed ID: 23604623
[TBL] [Abstract][Full Text] [Related]
14. A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability.
Leoni G; D'Alise AM; Cotugno G; Langone F; Garzia I; De Lucia M; Fichera I; Vitale R; Bignone V; Tucci FG; Mori F; Leuzzi A; Di Matteo E; Troise F; Abbate A; Merone R; Ruzza V; Diodoro MG; Yadav M; Gordon-Alonso M; Vanhaver C; Panigada M; Soprana E; Siccardi A; Folgori A; Colloca S; van der Bruggen P; Nicosia A; Lahm A; Catanese MT; Scarselli E
Cancer Res; 2020 Sep; 80(18):3972-3982. PubMed ID: 32690723
[TBL] [Abstract][Full Text] [Related]
15. Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome.
Reuschenbach M; Kloor M; Morak M; Wentzensen N; Germann A; Garbe Y; Tariverdian M; Findeisen P; Neumaier M; Holinski-Feder E; von Knebel Doeberitz M
Fam Cancer; 2010 Jun; 9(2):173-9. PubMed ID: 19957108
[TBL] [Abstract][Full Text] [Related]
16. T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer.
Bauer K; Nelius N; Reuschenbach M; Koch M; Weitz J; Steinert G; Kopitz J; Beckhove P; Tariverdian M; von Knebel Doeberitz M; Kloor M
Cancer Immunol Immunother; 2013 Jan; 62(1):27-37. PubMed ID: 22729559
[TBL] [Abstract][Full Text] [Related]
17. Inflammation-Associated Microsatellite Alterations Caused by MSH3 Dysfunction Are Prevalent in Ulcerative Colitis and Increase With Neoplastic Advancement.
Munakata K; Koi M; Kitajima T; Tseng-Rogenski S; Uemura M; Matsuno H; Kawai K; Sekido Y; Mizushima T; Toiyama Y; Yamada T; Mano M; Mita E; Kusunoki M; Mori M; Carethers JM
Clin Transl Gastroenterol; 2019 Dec; 10(12):e00105. PubMed ID: 31789935
[TBL] [Abstract][Full Text] [Related]
18. Loss of MSH3 protein expression is frequent in MLH1-deficient colorectal cancer and is associated with disease progression.
Plaschke J; Krüger S; Jeske B; Theissig F; Kreuz FR; Pistorius S; Saeger HD; Iaccarino I; Marra G; Schackert HK
Cancer Res; 2004 Feb; 64(3):864-70. PubMed ID: 14871813
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel HLA-A*0201-restricted epitopes from anterior gradient-2 as a tumor-associated antigen against colorectal cancer.
Lee HJ; Hong CY; Jin CJ; Kim MH; Lee YK; Nguyen-Pham TN; Lee H; Park BC; Chung IJ; Kim HJ; Lee JJ
Cell Mol Immunol; 2012 Mar; 9(2):175-83. PubMed ID: 22231555
[TBL] [Abstract][Full Text] [Related]
20. Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors.
Woerner SM; Tosti E; Yuan YP; Kloor M; Bork P; Edelmann W; Gebert J
Mol Carcinog; 2015 Nov; 54(11):1376-86. PubMed ID: 25213383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
